HEALTH CARE UTILIZATIONS AND COSTS OF INSULIN PATIENT-DRIVEN TITRATION VERSUS PHYSICIAN-DRIVEN TITRATION: EVIDENCE BASED ON A CLINICAL TRIAL OF BIPHASIC INSULIN ASPART 30 TWICE DAILY IN PEOPLE WITH TYPE 2 DIABETES IN CHINA
机构：[1]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Hebei Med Univ, Hosp 3, Shijiazhuang, Peoples R China[3]Jiangxi Prov Peoples Hosp, Nanchang, Peoples R China[4]Novonordisk China Pharmaceut Ltd, Beijing, Peoples R China[5]Binzhou Med Univ, Yantai Affiliated Hosp, Yantai, Peoples R China
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Yang J.,Liu K.,Liu J.,et al.HEALTH CARE UTILIZATIONS AND COSTS OF INSULIN PATIENT-DRIVEN TITRATION VERSUS PHYSICIAN-DRIVEN TITRATION: EVIDENCE BASED ON A CLINICAL TRIAL OF BIPHASIC INSULIN ASPART 30 TWICE DAILY IN PEOPLE WITH TYPE 2 DIABETES IN CHINA[J].VALUE IN HEALTH.2014,17(7):A743-A743.doi:10.1016/j.jval.2014.08.154.
APA：
Yang, J.,Liu, K.,Liu, J.,Zhang, Y.&Song, S..(2014).HEALTH CARE UTILIZATIONS AND COSTS OF INSULIN PATIENT-DRIVEN TITRATION VERSUS PHYSICIAN-DRIVEN TITRATION: EVIDENCE BASED ON A CLINICAL TRIAL OF BIPHASIC INSULIN ASPART 30 TWICE DAILY IN PEOPLE WITH TYPE 2 DIABETES IN CHINA.VALUE IN HEALTH,17,(7)
MLA：
Yang, J.,et al."HEALTH CARE UTILIZATIONS AND COSTS OF INSULIN PATIENT-DRIVEN TITRATION VERSUS PHYSICIAN-DRIVEN TITRATION: EVIDENCE BASED ON A CLINICAL TRIAL OF BIPHASIC INSULIN ASPART 30 TWICE DAILY IN PEOPLE WITH TYPE 2 DIABETES IN CHINA".VALUE IN HEALTH 17..7(2014):A743-A743
